Madison El-Saadi
Stock Analyst at B. Riley Securities
(3.14)
# 1,280
Out of 5,157 analysts
13
Total ratings
53.85%
Success rate
15.79%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Madison El-Saadi
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARWR Arrowhead Pharmaceuticals | Maintains: Buy | $61 → $101 | $58.10 | +73.84% | 1 | Jan 22, 2026 | |
| VNDA Vanda Pharmaceuticals | Maintains: Buy | $11 → $14 | $9.29 | +50.70% | 2 | Dec 31, 2025 | |
| CAPR Capricor Therapeutics | Reiterates: Buy | $21 → $50 | $33.57 | +48.94% | 2 | Dec 15, 2025 | |
| WVE Wave Life Sciences | Maintains: Buy | $19 → $37 | $14.08 | +162.78% | 4 | Dec 12, 2025 | |
| AXSM Axsome Therapeutics | Initiates: Buy | $179 | $159.50 | +12.23% | 1 | Oct 1, 2025 | |
| ETON Eton Pharmaceuticals | Reiterates: Buy | $24 → $26 | $18.09 | +43.73% | 3 | May 16, 2025 |
Arrowhead Pharmaceuticals
Jan 22, 2026
Maintains: Buy
Price Target: $61 → $101
Current: $58.10
Upside: +73.84%
Vanda Pharmaceuticals
Dec 31, 2025
Maintains: Buy
Price Target: $11 → $14
Current: $9.29
Upside: +50.70%
Capricor Therapeutics
Dec 15, 2025
Reiterates: Buy
Price Target: $21 → $50
Current: $33.57
Upside: +48.94%
Wave Life Sciences
Dec 12, 2025
Maintains: Buy
Price Target: $19 → $37
Current: $14.08
Upside: +162.78%
Axsome Therapeutics
Oct 1, 2025
Initiates: Buy
Price Target: $179
Current: $159.50
Upside: +12.23%
Eton Pharmaceuticals
May 16, 2025
Reiterates: Buy
Price Target: $24 → $26
Current: $18.09
Upside: +43.73%